Zobrazeno 1 - 10
of 252
pro vyhledávání: '"Richard A Yost"'
Autor:
Richard A. Yost
Publikováno v:
Journal of Mass Spectrometry and Advances in the Clinical Lab, Vol 24, Iss , Pp 90-99 (2022)
Externí odkaz:
https://doaj.org/article/2cf1a168b6d6444b94b90e1a5cffb31a
Autor:
Jeremy P. Koelmel, Wan Y. Tan, Yang Li, John A. Bowden, Atiye Ahmadireskety, Andrew C. Patt, David J. Orlicky, Ewy Mathé, Nicholas M. Kroeger, David C. Thompson, Jason A. Cochran, Jaya Prakash Golla, Aikaterini Kandyliari, Ying Chen, Georgia Charkoftaki, Joy D. Guingab‐Cagmat, Hiroshi Tsugawa, Anmol Arora, Kirill Veselkov, Shunji Kato, Yurika Otoki, Kiyotaka Nakagawa, Richard A. Yost, Timothy J. Garrett, Vasilis Vasiliou
Publikováno v:
Hepatology Communications, Vol 6, Iss 3, Pp 513-525 (2022)
Alcoholic fatty liver disease (AFLD) is characterized by lipid accumulation and inflammation and can progress to cirrhosis and cancer in the liver. AFLD diagnosis currently relies on histological analysis of liver biopsies. Early detection permits in
Externí odkaz:
https://doaj.org/article/d5f7be9683684d59b0c25b597814b71a
Autor:
Hoda Safari Yazd, Vanessa Y. Rubio, Casey A. Chamberlain, Richard A. Yost, Timothy J. Garrett
Publikováno v:
Journal of Mass Spectrometry and Advances in the Clinical Lab, Vol 20, Iss , Pp 11-24 (2021)
Introduction: Intellectual disorders involving deletions of the X chromosome present a difficult task in the determination of a connection between symptoms and metabolites that could lead to treatment options. One specific disorder of X-chromosomal d
Externí odkaz:
https://doaj.org/article/8cc8834011b2435e8fad6733b993e682
Publikováno v:
Journal of Lipid Research, Vol 61, Iss 3, Pp 275-290 (2020)
Diets high in calories can be used to model metabolic diseases, including obesity and its associated comorbidities, in animals. Drosophila melanogaster fed high-sugar diets (HSDs) exhibit complications of human obesity including hyperglycemia, hyperl
Externí odkaz:
https://doaj.org/article/1caa21af52fe42738ba5bcf83ad29800
Autor:
Atiye Ahmadireskety, Bianca F. Da Silva, Jill A. Awkerman, Joe Aufmuth, Richard A. Yost, John A. Bowden
Publikováno v:
Environmental Advances, Vol 5, Iss , Pp 100088- (2021)
Sediment samples from 25 locations in the Pensacola Bay System (PBS) watershed were analyzed for the presence of 51 per- and polyfluoroalkyl substances (PFAS) using ultra high-performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) a
Externí odkaz:
https://doaj.org/article/3a037f8f864446839890c8268e50f5ad
Autor:
Jeremy P. Koelmel, Jason A. Cochran, Candice Z. Ulmer, Allison J. Levy, Rainey E. Patterson, Berkley C. Olsen, Richard A. Yost, John A. Bowden, Timothy J. Garrett
Publikováno v:
BMC Bioinformatics, Vol 20, Iss 1, Pp 1-13 (2019)
Abstract Background Lipidomics, the comprehensive measurement of lipids within a biological system or substrate, is an emerging field with significant potential for improving clinical diagnosis and our understanding of health and disease. While lipid
Externí odkaz:
https://doaj.org/article/12f50269baf64f3d8c2932396d7b0de3
Autor:
Jiajun Lei, Rohit Mahar, Mario C. Chang, James Collins, Matthew E. Merritt, Timothy J. Garrett, Richard A. Yost
Publikováno v:
Analytical Chemistry. 95:1908-1915
Autor:
Jeremy P. Koelmel, Nicholas M. Kroeger, Candice Z. Ulmer, John A. Bowden, Rainey E. Patterson, Jason A. Cochran, Christopher W. W. Beecher, Timothy J. Garrett, Richard A. Yost
Publikováno v:
BMC Bioinformatics, Vol 18, Iss 1, Pp 1-11 (2017)
Abstract Background Lipids are ubiquitous and serve numerous biological functions; thus lipids have been shown to have great potential as candidates for elucidating biomarkers and pathway perturbations associated with disease. Methods expanding cover
Externí odkaz:
https://doaj.org/article/24d0b49e7e954a8da7e3dbc92d2574d8
Publikováno v:
Analytical and Bioanalytical Chemistry. 414:5549-5559
Autor:
Xue Li, Tian Zhu, Richard Rubenstein, Kevin K.W. Wang, Richard A Yost, Yuan Shi, Zhihui Yang, George Anis Sarkis, Geoffrey T. Manley
Publikováno v:
Biomark Med
Aim: There is a critical need to validate biofluid-based biomarkers as diagnostic and drug development tools for traumatic brain injury (TBI). As part of the TBI Endpoints Development Initiative, we identified four potentially predictive and pharmaco